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ABSTRACT 
Objective: The objective of the present study was to develop an HPLC analytical method and to perform in vivo study of Emblica officinalis and Aegle 
marmelos extracts for antioxidant and antidiabetic activity. 
Methods: The phytochemical analyses, total phenolic content (TPC), TLC, DPPH assay were performed for freeze-dried Emblica officinalis fruits 
aqueous extract (EOFAE) and Aegle marmelos leaves ethyl acetate extract (AMLEAE). The active constituents present in both extracts were 
estimated by using HPLC system having Hibar®
Results: Tannins, saponins, carbohydrate, glycosides are found in EOFAE; coumarins and flavonoids are found in AMLEAE and quinones, phenols 
are present in both extracts. The values of TPC present in standard gallic acid, EOFAE and AMLEAE were found to be 485.7, 315.6, 300.7 mgGAE/g, 
respectively. R
 C18 column [250 x4.6 mm, 5 µm] and UV detector (264 nm). A gradient mobile phase (acetonitrile 
and water with 0.1% trifluoroacetic acid) was used at a flow rate of 0.8 ml/min. In vivo antioxidant, antidiabetic activity of both extracts was 
conducted on male albino Wistar rats for 21 d in streptozotocin-induced diabetic rats (42 rats; n=6). The antidiabetic activity was measured by 
blood glucose level and biochemical parameters i.e. total cholesterol, triglycerides and total protein. Oxidative stress was measured by antioxidant 
biomarkers i.e. SOD, GSH, lipid peroxidation by thiobarbituric acid reactive substances method on the liver of the experimental rat. 
f 
Conclusion: The present study showed that the EOFAE and AMLEAE treated group III with (EOAM) low dose of 500 mg/kg body weight has potent 
antioxidant and antidiabetic activity.  
values obtained by TLC of EOFAE and AMLEAE were found to be 0.41 and 0.50, respectively. The values of % inhibition shown by 
EOFAE and AMLEAE in DPPH assay were found to be 97.8%±2 and 95.2%±2, respectively. The values of retention time of EOFAE and AMLEAE by 
HPLC analysis were found to be 4.59 and 5.28 min, respectively. Histopathological examination of the liver was revealed that low dose EOAM 
(containing of EOFAE 250+AMLEAE 250 mg/kg body weight) administered once a daily for 21 d showed significant activity (P˂ 0.001) with 
biochemical parameters and antioxidant biomarkers. 
Keywords: Emblica officinalis, Aegle marmelos, Antioxidant, Antidiabetic activity, streptozotocin, HPLC 




World Health Organisation (WHO) states that an estimated 1.6 
million deaths were directly caused by diabetes in 2015 and projects 
that this disorder will be 7th leading cause of death in 2030 [1]. 
Indian Council of Medical Research (ICMR) and the American 
Diabetes Association are working accordingly for the prevention and 
treatment of this disorder [2-4]. Diabetes mellitus is a chronic 
metabolic disorder caused by inherited and/or acquired deficiency 
in production insulin by the pancreas or by the ineffectiveness of the 
insulin produced. Such a deficiency results in increased 
concentrations of glucose in the blood, which in turn damage many 
of the body’s systems, in particular, the blood vessels and nerves [5]. 
It affects all the vital organs such as heart, nerves, eyes, kidney, foot 
and associated with the chronic complications likes nephropathy, 
neuropathy, retinopathy and cardiovascular diseases. The most 
common types of diabetes are type 1-diabetes (insulin-dependent) 
in which the pancreas fails to produce the insulin which is essential 
for survival. This form develops most frequently in children, 
adolescents and they need to take insulin every day to stay alive. 
Type 2-diabetes (non-insulin dependent) occur due to reduce insulin 
secretion and insulin sensitivity. It mostly occurs in middle-aged and 
old-aged people. Gestational diabetes occurs in some pregnant 
women [6]. Oral hypoglycaemic agents like sulfonylureas, 
biguanides and thiazolidinediones are used in the treatment of type 
2 diabetes. 
MATERIALS AND METHODS 
These drugs are required throughout life in most of the 
cases. Various side effects of these drugs are stomach upset, skin 
rash, kidney complications, dizziness, metal taste, gas, bloating and 
diarrhea, risk of liver disease. In the case of diabetes mellitus blood, 
glucose level and oxidative stress are high which increase the 
number of free radicals present in the body. Free radicals are highly 
reactive in other words increasing in oxidative stress [7]. The 
constituents of medicinal plants activate free radical scavenging 
enzymes and have antioxidant activity as well as antidiabetic activity 
[8]. Various parts of medicinal plants like leaves, roots, bark and 
fruit are used by Ayurvedic practitioners for different therapeutic 
effects as they are safe, economical, least adverse effects [9]. 
Literature reports that water-soluble [10] extract of Emblica 
officinalis has potent antioxidant activity and hypoglycemic activity 
[11]. Emblica officinalis Gaertn. is also known as “Amla” traditionally, 
belonging to the family Euphorbiaceae [12]. It is one of the most 
important plants of Ayurveda and traditional Indian medicine [11]. 
Other reports indicate that marmelosin present in Aegle marmelos 
has antidiabetic activity [13-16]. Marmelosin (Imperatorin) is freely 
soluble in ethyl acetate extract [14]. Aegle marmelos traditionally 
also known as bael (golden apple) in India, which is belonging to 
family Rutaceae and one of the most important plant in the 
Ayurveda [15]. Components present in the leaf of Aegle marmelos 
have the ability to inhibit aldose reductase and help in delaying the 
progression of diabetic cataract [14]. Proposed project involves the 
co-administration of aqueous extract of Emblica officinalis fruits and 
ethyl acetate extract of Aegle marmelos leaves for antioxidant and 
antidiabetic activity. 
Shade-dried fruits of Emblica officinalis and leaves of Aegle marmelos 
were purchased from Green Pharmacy, Pune (Auth. 18-13, Auth. 18-
14) Maharashtra, India. Both drugs were authenticated from 
Agharkar Research Institute, Pune, India. HPLC grade of 
Acetronitrile, AR grade of Ascorbic acid, gallic acid were purchased 
from Loba-chemie, Mumbai, India. Streptozotocin was purchased 
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from Enzo Life Science, UK. Diagnostic kits were procured from 
Biolab, Span and Tulip diagnostic Pvt. Ltd., Boisar, Maharashtra, 
India. Glibenclamide was purchased from Torrent Pharmaceuticals, 
Ltd, Bhat, Gandhinagar, Gujarat, India. Male Albino Wistar rats were 
obtained from Global Bioresearch Solution Pvt. Ltd., Pune, India. 
Instruments 
The analytical method was performed on Shimadzu HPLC (LC 2010 
CHT, Japan) having a quaternary system with automatic injection 
facility, LC solution software and UV visible detector. The column 
used was Purospher Star RP-18e, Hibar C-18 (250 mm x 4.6 mm, 5 
µm). Shimadzu (UV-1800) UV-visible spectrometer, Bruker (Alpha-T 
model) FT-IR, Martin Christ (Alpha 1-2 LD plus) Freeze dryer, 
Equiptronics (EQ-610) digital pH meter and Shimadzu (AYT 224) 
analytical balance were employed for this study. 
Preparation of extracts 
Preparation of Emblica officinalis fruits extract 
Shade-dried powder of the Emblica officinalis fruits (50 gm) was 
macerated with 500 ml of water for 24 h at 25-30 °C with occasional 
shaking and filtered through a muslin cloth and then filtered through 
Whatman filter paper (0.45µ). Filtrate was freeze-dried under 
vaccum at -50°C±2°C to get dry powder. Freeze-dried extract were 
stored at below 4 °C until further use [10, 12]. 
Preparation of Aegle marmelos leaves extract 
Shade-dried powder of Aegle marmelos leaves (150 gm) was 
macerated with 300 ml of ethyl acetate for 72 h at 25-30 °C in a 
suitable container. The solvent evaporation was protected by 
wrapping of the container with aluminium foil. The menstruum was 
filtered through muslin cloth and then filtered through Whatman filter 
paper (0.45µ). Filtrate was concentrated by using a vaccum rotary 
evaporator and kept it at 37 °C to remove any traces of solvent. This 
concentrated extract was freeze-dried under vaccum at-50 °C±2 °C to 
get the dry powder and stored at below 4 °C until further use [14]. 
Phyto-chemical investigation 
Both the extracts were evaluated for preliminary phytochemical 
investigation and alkaloids, tannins, proteins, saponins, quinones, 
coumarins, phenols, flavonoids, carbohydrates, glycosides and 
sterols tests were performed [12]. 
Total phenolic content 
Total phenolic content of EOFAE and AMLEAE was determined by the 
Folin-Ciocalteu method. Each extract (150 µl) was mixed with 0.5 ml of 
Folin-Ciocalteu phenol reagent and stand for 5 min and then 350 µl of 
10% Na2CO3was added. Each reaction mixture was incubated for 2 h 
period at room temperature and absorbance was measured at 765 nm 
by using double beam UV visible spectrophotometer. The standard 
gallic acid solution in methanol was prepared in the range of 
concentrations 0.2, 0.4, 0.6, 0.8 and 1 mg/ml [12, 17].  
Thin layer chromatography (TLC) 
Acetonitrile: 0.1% trifluoroacetic acid in water in the ratio 2.5: 7.5 
v/v was used as a mobile phase for TLC of EOFAE. 
Toluene: ethyl acetate: glacial acetic acid: methanol in the ratio 8: 2: 
0.2: 0.2 v/v was used as a mobile phase for TLC of AMLEAE [18]. 
In vitro antioxidant assay 
DPPH (1,1-diphenyl-2-picrylhydrazyl) free radical scavenging 
activity 
DPPH radical scavenging method developed by Blois was used [12, 
19-21]. Antioxidant activity of the each extract was compared with 
the natural antioxidant ascorbic acid. Stock solution of DPPH was 
prepared by dissolving 24 mg of DPPH in 100 ml of methanol and 
stored at-20 °C. Working standard solution was prepared by 10 ml of 
the stock solution to 45 ml of methanol and absorbance was 
recorded at 515 nm. Extracts of both drugs (100µg/ml) were added 
to 2.85 µl of DPPH working standard and kept in dark for 30 min. 
The absorbances of both solutions were measured at 515 nm. 
Control was prepared in the same manner without the addition of 
the extract. Percent inhibition of DPPH free radical was calculated by 
the following formula:  
Inhibition (%) = [(Acontrol-Atest)/Acontrol
Where A
]x 100 
control  is the absorbance of DPPH radical solution in 
methanol. Atest
HPLC method development 
 is the absorbance of DPPH radical solution mixed 
with each extract.  
Detection wavelengths for HPLC analysis were selected by scanning 
100 µg/ml solution of each extract separately by double beam UV-
visible spectrophotometer in the range of 200-400 nm. Stationary 
phase ODS in Hibar®
Preparation of the mobile phase 
C18 column [250 x4.6 mm,5 µm] was used in 
HPLC. Standard solutions of both extracts were prepared separately 
for HPLC analysis [22].  
Solvents (HPLC grade) of mobile phase (Acetonitrile and 0.1% v/v of 
TFA in water) were filtered through 0.45 µ membrane filter paper 
separately and sonicated to degas. These solvents were transferred 
in two different reservoirs of the HPLC system. 
Preparation of standard solutions 
100 mg of EOFAE was accurately weighed and transferred into the 100 
ml volumetric flask. It was then dissolved in water (HPLC grade) and 
volume was made up to the mark to prepare a standard stock solution. 
This solution was further diluted up to 100µg/ml with water.  
100 mg of AMLEAE was accurately weighed and transferred into the 
100 ml volumetric flasks. It was then dissolved in ethyl acetate and 
volume was made up to the mark to prepare a standard stock 
solution. This solution was further diluted up to 100µg/ml with 
ethyl acetate. 
Preparation of sample solutions 
Water (100 ml) was transferred to the separating funnel and 
accurately weighed the quantity of powder (equivalent to 200 mg of 
each extract) was added to it. The mixture was shaken and 100 ml of 
ethyl acetate was added to it. The resultant mixture was shaken for 
10 min and kept for 6 h with occasional shaking. The layers were 
separated and collected carefully. These solutions were further 
diluted suitably in the range of standard solutions. 
Fourier transform infrared (FT-IR) spectral analysis 
FT-IR analysis of EOFAE [24] and AMLEAE [25] was done for the 
presence of the functional group in extracts. The dry sample of each 
extract was mixed with potassium bromide (IR grade) in the ratio 
1:100. This mixture was compressed to form pellets by applying 10 
tons of pressure in hydraulic press. The pellet was scanned over a 
wave number range of 4000 to 400 cm-1
In vivo antidiabetic study 
 by using FT-IR instrument. 
Experimental animals 
The experimental protocol [SCOP/IAEC/17-18/07/252, dated 
23.02.2018] was approved by the Institutional Animal Ethics 
Committee (IAEC) of Sinhgad College of Pharmacy, Pune. Forty-two 
Male Albino Wistar rats of weight 180-240 g were used in this 
project. The animals were housed in large, spacious polypropylene 
cages with paddy husk as bedding at an ambient room temperature 
with 12 h light and dark cycle. The animals fed with standard pellet 
diet (Nutrivet Lab, Pune) and water ad libitum throughout the 
experimental duration. 
Induction of diabetes on experimental rats 
After adequate acclimatisation period, rats were randomly divided 
into normal control (group 1, n=6) and diabetic model (group 2, 
n=36). Freshly prepared streptozotocin (STZ) [in freshly prepared 
0.1 mol/l cold citrate buffer, pH 4.5] was administered 
intraperitoneally to an overnight fasted rat at a dose of 50 mg/kg 
body weight [8]. The STZ treated animals were allowed to drink 5% 
glucose solution overnight to overcome STZ-induced hypoglycaemia. 
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After 48h, rats with marked hyperglycemia (fasting blood glucose 
≥250 mg/dl) were selected and used for the study. 
Experimental animal grouping and treatment 
Diabetic animals were treated with low dose combination 
[EOAM] and high dose combination daily through oral gavage for 
three weeks and co-administration of glibenclamide with low or 
high dose of EOAM, glibenclamide (5 mg/kg). The suspension of 
EOAM was prepared with 2% of gum acacia. The diabetic animals 
were further divided into five groups consisting 6 animals each 
as follows,(1) group 3, low dose (containing of EOFAE 
250+AMLEAE 250 mg/kg bw), (2) group 4, high dose (containing 
of EOFAE 500+AMLEAE 500 mg/kg bw), (3) group 5, low dose 
with glibenclamide (low dose of each extract+glibenclamide5 
mg/kg body weight), (4) group 6, high dose with glibenclamide 
(high dose of each extract+glibenclamide5 mg/kg body weight) 
and(5) group 7, treated with glibenclamide5 mg/kg body weight 
used as reference drug [11]. 
Body weight 
Body weight was recorded at the end of three-week treatment by 
gravimetrically using the electronic digital balance. 
Biochemical analysis 
Rats were fasted overnight and the blood was withdrawn by 
retro-orbital puncture on 1st day and 21st day post-induction 
for the estimation of various biochemical parameters, i.e., total 
cholesterol, total triglyceride, total protein [28-31]. Blood 
sample was centrifuged for 20 min at 5000 rpm at 37 °C and 
serum was separated for the biochemical estimation. All the 
analysis was completed within 24 h from sample collection. 
Blood glucose level (BGL) was determined by commercial 
glucometer by pricking tail vein. 
Estimation of oxidative stress 
At the end of treatment, the animals were allowed for fasting 16 
h and they were sacrificed by sodium pentobarbital then the 
liver was carefully removed, weighed and washed with ice-cold 
saline. One gram of liver was homogenized with buffer 
containing 0.25 M sucrose and 0.1 M Tris-HCL buffer solution 
(pH 7.4). The homogenate was centrifuged at 10000 x g for 10 
min at 0 °C in cold centrifuge; separated supernatant was again 
centrifuged at 10000 x g for 30 min and then used for the 
antioxidant enzyme estimations [8]. Antioxidant enzymes were 
estimated by SOD, GSH and LPO. A level of superoxide dismutase 
(SOD) was estimated, reduced glutathione (GSH) was estimated 
by the method of Ellman (1959), and lipid peroxidation was 
estimated by thiobarbituric acid reactive substances (TBARS) 
method was done [8-9, 32-34]. 
Histopathology 
At the end of the experiment, whole liver from each animal were 
collected in 10% formalin solution and an immediately processed 
using paraffin technique. Thin section (5 µm) were cut and stained 
with hematoxylin and eosin. The tissue sample was examined and 
observed under a light microscope for structural abnormality. 
Statistical analysis 
All data sets were expressed as the mean±SEM (n=6). Data sets were 
subjected to One-way analysis of variance (ANOVA) followed by the 
Tukey’s test. p<0.05 was considered as a minimum level of 
significance. Statistical analysis was performed using the software 
GraphPad prism 5.01. 
RESULTS AND DISCUSSION 
Aqueous extract of Emblica officinalis fruit was selected because active 
constituents are water-soluble, i.e. ascorbic acid and tannins like 
emblicanin A and B which are antioxidant. Similarly, ethyl acetate extract 
of Aegle marmelos leaves was selected because active constituent 
marmelosin is soluble in it. The % yield was obtained for the EOFAE and 
AMLEAE 30 %and 5.33 %, respectively. Results of phytochemical 
investigation for EOFAE and AMLEAE are shown in table 1. 
Total phenolic content  
The total phenolic contents of gallic acid, EOFAE and AMLEAE were 
found to be 485.7, 315.6 and 300.7 milligrams of gallic acid 
equivalent per gram of dried extract (mgGAE/g), respectively. These 
results indicated that EOFAE and AMLEAE have sufficient phenolic 
content for antioxidant activity. 
 
Thin layer chromatography 
 
Fig. 1: TLC for EOFAE 
 
TLC showed single dark brown colour spot in normal day light at Rf
 
 
value at 0.41 for ascorbic acid as shown in fig. 1. 
 
Fig. 2: TLC for AMLEAE (a) under UV light and (b) in normal day light 
 
TLC showed a single dark violet colour spot was observed under UV 
light and in normal day light at Rf
Antioxidant assay by in vitro 
 value at 0.5for marmelosin as 
shown in fig. 2.  
DPPH (1, 1-diphenyl-2-picrylhydrazyl) free radical scavenging 
activity 
DPPH is a stable free radical that reacts with compounds that can donate 
a hydrogen atom. The decline capability of DPPH radical is determined 
by the decrease in absorbance at 515 nm induced by antioxidants. The 
extracts are able to reduce the stable radical DPPH to the yellow-
coloured diphenylpicryl hydrazine. The free radical scavenging activity 
was shown 97.08% by EOFAE and 95.06% by AMLEAE shown in fig. 3. 
Optimization of chromatographic conditions 
The significant absorbance of both extracts was found at 264 nm; 
therefore this wavelength was selected as the detection wavelength 
for analysis of both extract by HPLC. Initially, various 
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chromatographic conditions were tried for both extracts separately, 
in order to obtain better separation characteristics by changing 
mobile phase composition. Finally, the mobile phase containing 
acetonitrile: water (0.1% trifluoroacetic acid) 15:85 was selected for 
analysis of EOFAE and acetonitrile: water (0.1% trifluoroacetic acid) 
13:87 was selected for analysis of AMLEAE. The flow rate of mobile 
phase for extracts was 0.8 ml/min. The values of retention time for 
an active constituent of EOFAE and AMLEAE were found at 4.59 and 
5.24 min, respectively. Optimized chromatographic conditions are 
mentioned in table 2 and fig. 4 (a) and (b). 
 
Table 1: Phyto-chemical investigation for EOFAE and AMLEAE 
 Phyto-chemical test Eofae Amleae 
Tannins (+) (-) 
Saponins (+) (-) 
Quinones (+) (+) 
Coumarins (-) (+) 
Phenols (+) (+) 
Carbohydrate (+) (-) 
Glycosides (+) (-) 
Flavonoids (-) (+) 
(+): Present, (-): Absent 
 
  
(a)      (b) 
Fig. 3: (a) Ascorbic acid standard curve, (b) shows DPPH (1, 1-diphenyl-2-picrylhydrazyl) % inhibition. Free radical scavenging activity 
for EOFAE and AMLEAE 
 
Table 2: Optimized chromatographic conditions 
S. No. Parameters Eofae Amleae 
1 Mobile phase Acetonitrile: water (0.1 % TFA) 
2 Column Purospher Star RP-18, Hibar C-18 (250 mm x 4.6 mm, 5 µm) 
3 Ratio 15: 85 v/v 17:83 v/v 
4 Flow rate 0.8 ml/min 0.8 ml/min 
5 Column temperature 30 °C 30 °C 
6 Detection wavelength 264 nm 264 nm 
7 Injection volume 30 µl 30 µl 
8 Run time 20 min 20 min 
9 Retention time 4.59 min 5.24 min 
10 Tailing factor 0.67 0.92 
11 Theoretical plates 13619.46 4640.40 
 
  
(a)      (b) 
Fig. 4: (a) Typical chromatogram of ascorbic acid in EOFAE; (b) Typical chromatogram of marmelosin in AMLEAE 
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FT-IR analysis of EOFAE and AMLEAE was done for the presence of functional group in extracts shown in fig. 5 (a) and (b). 
 
 
(a)      (b) 
Fig. 5: FT-IR spectum for (a) EOFAE(b) FT-IR for AMLEAE 
 
Biochemical analysis 
Diabetes is associated with weight loss. Body weight get reduces in 
diabetic rats due to the derangement of the metabolic pathway. It 
causes failure to use of glucose for energy, which leads to increased 
utilization and decreased storage of protein responsible for the 
reduction of body weight. The average body weight of the 
experimental animals was increased treatment period as shown in 
table 3. 
 
Table 3: Effect of three weeks of oral treatment of EOAM, glibenclamide and its combination in STZ-induced diabetic rats on body weight 
G. No. Groups Body weight (gm) 
I NC 210.2±0.97 
II DC (50) 164±2.73
III 
 
EOAM (EOFAE 250+ 




EOAM (EOFAE 500+ 




EOAM (EOFAE 250+ 




EOAM (EOFAE 500+ 




Glib (5) 247±9.63€ 
n = 6, values are expressed as mean±SEM, p<0.001 as compared to NWC, €
 
p<0.001 as compared to DC 
Blood Glucose Level in STZ-induced diabetic rats is significantly 
increased and reduced in the treatment groups shown in table 4. 
Diabetes mellitus is characterized by high blood glucose levels 
(hyperglycemia) due to the inability of the body’s cells to utilize 
glucose properly. Increased BGL in DM produces superoxide anions 
which generate hydroxyl radicals via Haber-Weiss reaction. 
Reduction in BGL in STZ-induced diabetic rats, which means may be 
there is the regeneration of insulin. 
  
Table 4: Effect of three weeks of oral treatment of EOAM, glibenclamide and its combination in STZ-induced diabetic rats on blood glucose 
level 
G. No.  Groups BGL (mg/dl) 
I NC 92.91±1.47 
II DC (50) 365.45±5.74
III 
 
EOAM (EOFAE 250+ 




EOAM (EOFAE 500+ 




EOAM (EOFAE 250+ 




EOAM (EOFAE 500+ 




Glib (5) 120.58±3.74€ 
n = 6, values are expressed as mean±SEM, p<0.001 as compared to NWC, €
 
p<0.001 as compared to DC 
Results of the biochemical analysis show that cholesterol and triglyceride 
were significantly increased and the total protein level was decreased in 
STZ-induced diabetes rats. Effect of EOAM on the lipid profile indicates the 
cholesterol (TC) and triglyceride (TG) were significantly reduced and total 
protein level (PROT) was increased in treatment groups as shown in table 
5. These results indicate that the effective antidiabetic activity of EOAM. 
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Table 5: Effect of three weeks of oral treatment of EOAM, glibenclamide and its combination in STZ-induced diabetic rats on lipid profile 
G. No. Groups TC (mg/dl) TG (mg/dl) TP (gm/dl) 
I NC 95.69±1.89 62±1.06 6.07±0.03 
II DC (50) 191.11±3.28 165.90±1.28 3.65±0.01 
III 
 
EOAM (EOFAE 250+AMLEAE 250 mg/kg bw) 105.79±2.92 70.88±1.29€ 5.80±0.18€ 
IV 
€ 
EOAM (EOFAE 500+AMLEAE 500 mg/kg bw) 110.49±6.32 74.91±1.00€ 5.32±0.14€ 
V 
€ 
EOAM (EOFAE 250+AMLEAE 250 mg/kg bw)+Glib (5) 106.76±2.49 69.97±1.81€ 5.61±0.13€ 
VI 
€ 
EOAM (EOFAE 500+AMLEAE 500 mg/kg bw)+Glib (5) 109.16±3.82 75.22±1.35€ 5.54±0.24€ 
VII 
€ 
Glib (5) 110.1±4.31 69.58±1.09€ 6.06±0.10€ € 
n = 6, values are expressed as mean±SEM, p<0.001 as compared to NWC, €
 
p<0.001 as compared to DC 
Diabetes is strongly co-related with oxidative stress induction. 
Lipid peroxidation is one of the characteristic features of 
diabetes mellitus and it is measured by TBARS (MDA) was used 
as an index of lipid peroxidation and it helps to assess the extent 
of tissue damage. By antioxidant assay results were found to be 
after three-week treatment that an increase in MDA level 
(Malondialdehyde) in liver of diabetic control animals. Oxidative 
stress in diabetes is coupled to a decrease in the antioxidant 
status, which can increase the deleterious effects of free radical. 
The SOD is the major scavenging enzymes that remove free 
radicals. Reduce activities of this antioxidant enzyme in liver 
tissue have been observed in diabetic animal and it may result in 
a number of deleterious effects due to an accumulation of 
superoxide anion and hydrogen peroxide, which in turn generate 
hydroxyl radicals, resulting in initiation and propagation of LPO. 
SOD protects from oxygen free radicals by catalyzing the 
removal of superoxide radical, which damage the membrane and 
biological structures. SOD and GSH level significantly increase 
and decrease in MDA level (shown in table 5) in the treatment 
groups which means that the treatment groups shows a 
combination of both extract can reduce the potential glycation of 
enzymes and could exert a beneficial action against pathological 
alteration caused by the presence of superoxide radicals, reduces 
the risk of tissue damage. Glutathione (GSH) is a tripeptide, 
intracellular antioxidant and protects the cellular system from 
adverse effects of LPO. Increase in aldehyde product of LPO has 
probably decreased GSH content and from the present study 
resulting in the elevation of the GSH level, which protects the cell 
membrane against oxidative damage by regulating the redox 
status of protein in the membrane [8]. 
  
Table 5: Effect of EOAM on level of SOD, GSH and MDA after 3 w 
G. No. Groups In vivo antioxidant parameter 
SOD (units/mg of protein) GSH (µM/mg of protein) MDA (n mol/mg of protein) 
I NC 8.74±0.27 9.07±0.28 7.00±0.14 
II DC (50) 4.93±0.17 5.07±0.17 11.03±0.51 
III 
 
EOAM (EOFAE 250+ 
AMLEAE 250 mg/kg bw) 
7.97±0.27 8.31±0.23€ 6.50±0.27€ 
IV 
€ 
EOAM (EOFAE 500+ 
AMLEAE 500 mg/kg bw) 
7.23±0.26 7.93±0.35€ 6.95±0.39€ 
V 
€ 
EOAM (EOFAE 250+ 
AMLEAE 250 mg/kg bw)+Glib (5) 
7.40±0.46 7.37±0.35€ 6.64±0.003€ 
VI 
€ 
EOAM (EOFAE 500+ 
AMLEAE 500 mg/kg bw)+Glib (5) 
7.21±0.03 7.62±0.49€ 6.73±0.43€ 
VII 
€ 
Glib (5) 6.78±0.001 7.79±0.47€ 6.54±0.15€ € 
n = 6, values are expressed as mean±SEM, p<0.001 as compared to NWC, €
 
p<0.001 as compared to DC. 
 
Fig. 6: Effect of three weeks of oral treatment of EOAM, glibenclamide and its combination in STZ-induced diabetic rats on antioxidant 
level 
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(I) NC (II) DC (50) 
  
(III) EOAM (EOFAE 250+AMLEAE 250 mg/kg bw) (IV) EOAM (EOFAE 500+AMLEAE 500 mg/kgbw) 
  
(V) EOAM (EOFAE 250+AMLEAE 250+Glib 5 mg/kg bw) (VI) EOAM (EOFAE 500+AMLEAE500+Glib 5 mg/kg bw) 
 
(VII) Glibenclamide 5 mg/kg bw 
Fig. 12: Histopathological examination of experimental rat liver after 21 d treatment (HandE, 400 X magnifications). Liver section of (I) Normal 
control, (II)Diabetic control,(III)EOAM (EOFAE 250+AMLEAE250 mg/kg bw),(IV) EOAM (EOFAE 500+AMLEAE 250 mg/kg bw, Combination of 
(V)EOAM (EOFAE 500+AMLEAE250+Glib 5 mg/kg bw),(VI)EOAM (EOFAE 500+AMLEAE 250+Glib 5 mg/kg bw),(VII)Glibenclamide5 mg/kg 
bw.[Hepatocyte (HC), Normal Portal Triad (P), Hepatocellular Vacuolation (V), Portal Triad (P) and Hepatocyte (H)] 
 
Histopathological studies 
Histopathological examination of the experimental rat liver after 21 
d treatment indicates that the liver section of normal control rats 
(NC) did not revealed any lesion of pathological significance as 
shown in fig. 12 (I). Liver section of diabetic control rat showed 
multifocal moderate hepatocellular vacuolation (microvesicular) as 
shown in fig. 12 (II). Liver section of diabetes-induced rats treated 
with low dose and high dose did not revealed any lesion of 
pathological significance as shown in fig. 12 (III) and (IV). 
Combination of low dose and high dose with glibenclamide also did 
not revealed any lesion of pathological significance as shown in fig. 
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12 (V) and (VI). Standard drug did not revealed any lesion of 
pathological significance as shown in fig. 12 (VII). Histopathology of 
the liver of STZ induced diabetic animals showed that there were 
hepatic changes, mild portal inflammation and hepatocellular 
vacuolation. After treatment of the animals by EOAM and 
glibenclamide, there was normal histology and reduced severity of 
the histopathological changes caused by STZ. The present study 
shows that the EOAM treated group III have significant antioxidant 
and antidiabetic activity as compare to diabetic control STZ induced 
animals. Equiproportion combination of both extracts shows 
significantly decreased in oxidative stress as evidenced by improved 
activities of antioxidant enzymes like superoxide dismutase, reduced 
glutathione. From the histological studies the liver section of group V 
and VI may have some interactions and liver section of diabetes-
induced rats groups III, IV treated with EOAM and VII treated with well 
known sulfonylurea drugs like glibenclamide did not revealed any 
lesion of pathological significance, where the group III shows good 
significant effect (p<0.001) as compare to STZ-induced diabetic rats. 
Conclusion: From the phytochemical investigation, hydrolyzable 
phytoconstituents like ascorbic acid, tannins like emblicanin A and B 
present in the aqueous extract which helps to increase the 
antioxidant activity and marmelosin present in the Aegle marmelos 
ethyl acetate extract which have potent antidiabetic activity. In vitro, 
antioxidant assay shows that both extracts have significant 
antioxidant activity. In vivo study reveals that the group III treated 
with EOAM (containing EOFAE 250+AMLEAE 250 mg/kg body 
weight) shows more significant in the reduction of blood glucose 
level, cholesterol, triglycerides, MDA level and concomitant increase 
in the serum protein level, SOD and GSH activities as compared to 
STZ-induced diabetic control rats. It can be concluded that 
equiproportion combination of both extracts exhibits synergistic 
effect, safe and has significant antioxidant and antidiabetic activity. 
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